NCT01356017 - CKD-828 Drug Interaction Study (Telmisartan) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Healthy Male Volunteers

Interventions

DRUG

Telmisartan 80mg, S-amlodipine 5mg

Telmisartan 80mg and S-amlodipine 5mg, Oral, Once a day, for 9 days + Wash out (19 days)

DRUG

Telmisartan 80mg

Telmisartan 80mg, Oral, Once a day, for 9 days + Wash out (19 days)

Trial Locations (1)

Asan Medical Center, Seoul